Stocklytics Platform
Asset logo for symbol OCUL
Ocular Therapeutix
OCUL69
$7.22arrow_drop_down0.20%-$0.01
Asset logo for symbol OCUL
OCUL69

$7.22

arrow_drop_down0.20%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Ocular Therapeutix (OCUL) Stocklytics Forecast

According to the latest stock market analysis, Ocular Therapeutix Inc (OCUL) is expected to experience positive growth in the coming years. The stock price prediction for OCUL indicates a steady increase in value, making it an attractive investment option. Analysts have forecasted that OCUL stock will continue to rise in value and reach new heights by 2023. In fact, machine learning predictions also support this projection, suggesting a favorable outcome for investors.
Financial experts have set a price target for Ocular Therapeutix Inc (OCUL) based on their analysis of the company's performance. The price target for OCUL in 2023 is predicted to be higher than the current stock price, indicating potential for substantial returns. Analysts believe that OCUL has strong growth prospects and recommend it as a good buy. The stock has received positive analyst ratings, further reinforcing its potential as a profitable investment.
add Ocular Therapeutix to watchlist

Keep an eye on Ocular Therapeutix

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Ocular Therapeutix (OCUL) stock?

Analysts have set a target price of $15.79 for Ocular Therapeutix (OCUL), based on forecasts from 28 analysts. The predicted price range extends from a high of $33 to a low of $9. This represents a potential increase of up to 356.62% and a decrease of 24.53% from the current price of $7.23. These forecasts are as of 2020 Dec 17.
help

What are the analyst ratings for Ocular Therapeutix (OCUL) stock?

The analyst ratings for Ocular Therapeutix (OCUL) are distributed as follows: 12 analysts recommend buying, 0 have a neutral stance, and 0 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Ocular Therapeutix .
help

What is the AI price prediction for Ocular Therapeutix (OCUL) stock?

At present, there is no AI or machine-learning-based price prediction available for Ocular Therapeutix (OCUL) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level